Thrivent Financial for Lutherans’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.99M | Sell |
|
|||||
|
2025
Q1 | $87.7M | Buy |
|
|||||
|
2024
Q4 | $89.2M | Buy |
|
|||||
|
2024
Q3 | $9.59M | Buy |
|
|||||
|
2024
Q2 | $8.21M | Sell |
|
|||||
|
2024
Q1 | $7.55M | Sell |
|
|||||
|
2023
Q4 | $8.78M | Sell |
|
|||||
|
2023
Q3 | $11.2M | Sell |
|
|||||
|
2023
Q2 | $64.3M | Sell |
|
|||||
|
2023
Q1 | $93.1M | Sell |
|
|||||
|
2022
Q4 | $120M | Buy |
|
|||||
|
2022
Q3 | $109M | Buy |
|
|||||
|
2022
Q2 | $73M | Buy |
|
|||||
|
2022
Q1 | $14.4M | Sell |
|
|||||
|
2021
Q4 | $33.5M | Sell |
|
|||||
|
2021
Q3 | $33.3M | Sell |
|
|||||
|
2021
Q2 | $30.8M | Buy |
|
|||||
|
2021
Q1 | $18.3M | Sell |
|
|||||
|
2020
Q4 | $28.1M | Buy |
|
|||||
|
2020
Q3 | $24.7M | Sell |
|
|||||
|
2020
Q2 | $28.1M | Buy |
|
|||||
|
2020
Q1 | $1.78M | Hold |
|
|||||
|
2019
Q4 | $1.37M | Buy |
|
|||||
|
2019
Q3 | $1.01M | Buy |
|
|||||
|
2019
Q2 | $1.1M | Buy |
|
|||||
|
2019
Q1 | $1.44M | Buy |
|
|||||
|
2018
Q4 | $1.26M | Buy |
|
|||||
|
2018
Q3 | $1.34M | Buy |
|
|||||
|
2018
Q2 | $1.12M | Buy |
|
|||||
|
2018
Q1 | $1.11M | Buy |
|
|||||
|
2017
Q4 | $1.18M | Buy |
|
|||||
|
2017
Q3 | $1.35M | Buy |
|
|||||
|
2017
Q2 | $1.4M | Buy |
|
|||||
|
2017
Q1 | $1.08M | Buy |
|
|||||
|
2016
Q4 | $962K | Buy |
|
|||||
|
2016
Q3 | $989K | Sell |
|
|||||
|
2016
Q2 | $1.56M | Buy |
|
|||||
|
2016
Q1 | $1.57M | Buy |
|
|||||
|
2015
Q4 | $1.21M | Buy |
|
|||||
|
2015
Q3 | $954K | Buy |
|
|||||
|
2015
Q2 | $995K | Buy |
|
|||||
|
2015
Q1 | $790K | Hold |
|
|||||
|
2014
Q4 | $718K | Hold |
|
|||||
|
2014
Q3 | $631K | Sell |
|
|||||
|
2014
Q2 | $523K | Sell |
|
|||||
|
2014
Q1 | $1.25M | Buy |
|
|||||
|
2013
Q4 | $495K | Hold |
|
|||||
|
2013
Q3 | $563K | Sell |
|
|||||
|
2013
Q2 | $585 | Buy |
|